In a pathological context, the over-expression of PrPC and RPSA frequently reported in several cancer types, can be the consequence of the genomic instability and it likely represents a mechanism through which the cells enhance the DDR to counteract the accumulation of DNA damage. The gene discussed is PRNP; the disease is cancer.